Company: TYRA
Filing Date: 2025-11-05
Form Type: 10-Q
Source: 0001193125-25-266967
Chunk: 1

Company: Tyra Biosciences, Inc.
Filing Date: 2025-11-05
Form: 10-Q
Item: Item 1
Chunk 1
---
 at September 30, 2025 and    December 31, 2024, respectively, and 53,318,198 and    50,749,945 shares outstanding at September 30, 2025 and    December 31, 2024, respectively.

     5

     5

     Additional paid-in capital

     617,486

     593,687

     Accumulated other comprehensive income

     442

     770

     Accumulated deficit

     (337,424
     )

     (251,311
     )

     Total stockholders’ equity

     280,509

     343,151

     Total liabilities and stockholders’ equity
      
     $
     301,851

     $
     363,558

See accompanying notes to unaudited condensed financial statements.